References
- Barbato A, Frischer T, Kuehni CE, Snijders D, Azevedo I, Baktai G, et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J. 2009;34: 1264–1276
- Ben-Chetrit E, Levy M. Familial Mediterranean fever. Lancet. 1998;351: 659–664
- Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med. 2004;169: 459–467
- Kennedy MP, Omran H, Leigh MW, Dell S, Morgan L, Molina PL, et al. Congenital heart disease and other heterotaxic defects in a large cohort of patients with primary ciliary dyskinesia. Circulation. 2007;115: 2814–2821
- Kuehni CE, Frischer T, Strippoli MP, Maurer E, Bush A, Nielsen KG, et al. Factors influencing age at diagnosis of primary ciliary dyskinesia in European children; ERS Task Force on Primary Ciliary Dyskinesia in Children. Eur Respir J. 2010;36: 1248–1258
- Zariwala MA, Omran H, Ferkol TW. The emerging genetics of primary ciliary dyskinesia. Proc Am Thorac Soc.. 2011;8: 430–433
- Stannard WA, Chilvers MA, Rutman AR, Williams CD, O’Callaghan C. Diagnostic testing of patients suspected of primary ciliary dyskinesia. Am J Respir Crit Care Med. 2010;181: 307–314
- Schwabe GC, Hoffmann K, Loges NT, Birker D, Rossier C, Santi MM, et al. Primary ciliary dyskinesia associated with normal axoneme ultrastructure is caused by DNAH11 mutations. Hum Mutat. 2008;29: 289–298
- Koh YY, Park Y, Jeong JH, Kim CK, Min YG, Chi JG. The effect of regular salbutamol on lung function and bronchial responsiveness in patients with primary ciliary dyskinesia. Chest. 2000;117: 427–433
- Phillips GE, Thomas S, Heather S, Bush A. Airway response of children with primary ciliary dyskinesia to exercise and beta2-agonist challenge. Eur Respir J. 1998;11: 1389–1391
- Ben-Chetrit E, Touitou I. Familial Mediterranean fever in the world. Arthr Rheum. 2009;61: 1447–1453
- Lidar M, Livneh A. Familial Mediterranean fever: clinical, molecular and management advancements. Neth J Med. 2007;65: 318–324.
- Yigit S, Karakus N, Tasliyurt T, Kaya SU, Bozkurt N, Kisacik B. Significance of MEFV gene R202Q polymorphism in Turkish familial Mediterranean fever patients. Gene. 2012;506: 43–45
- Giaglis S, Papadopoulos V, Kambas K, Doumas M, Tsironidou V, Rafail S, et al. MEFV alterations and population genetics analysis in a large cohort of Greek patients with familial Mediterranean fever. Clin Genet. 2007;71: 458–467
- Ben-Chetrit E, Levy M. Reproductive system in familial Mediterranean fever: an overview. Ann Rheum Dis. 2003;62: 916–919
- Tuglular S, Yalcinkaya F, Paydas S, Oner A, Utas C, Bozfakioglu S, et al. A retrospective analysis for aetiology and clinical findings of 287 secondary amyloidosis cases in Turkey. Nephrol Dial Transplant. 2002;17: 2003–2005
- Osman EM, Abboud Ol, Sulaiman SM, Musa AR, Beleil OM, Sharfi AA. End-stage renal failure in Kartagener’s syndrome. Nephrol Dial Transplant.. 1991;6: 747–748